Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Armata Pharmaceuticals Inc (ARMP)

Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Armata Pharmaceuticals Inc 5005 MCCONNELL AVENUE LOS ANGELES CA 90066 USA

www.armatapharma.com P: 310-665-2928

Description:

Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals Inc., formerly known as AmpliPhi Biosciences Corporation, is based in Marina del Rey, California.

Key Statistics

Overview:

Market Capitalization, $K 90,372
Enterprise Value, $K 100,522
Shares Outstanding, K 36,149
Annual Sales, $ 4,530 K
Annual Net Income, $ -69,050 K
Last Quarter Sales, $ 1,530 K
Last Quarter Net Income, $ -19,850 K
EBIT, $ -40,900 K
EBITDA, $ -39,930 K
60-Month Beta 0.85
% of Insider Shareholders 85.50%
% of Institutional Shareholders 3.57%
Float, K 5,242
% Float 14.50%
Short Volume Ratio 0.03

Growth:

1-Year Return 54.32%
3-Year Return -39.02%
5-Year Return -46.21%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 78.68%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.55 on 03/21/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -1.54
EPS Growth vs. Prev Qtr -77.42%
EPS Growth vs. Prev Year -89.66%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-14 on 05/10/19

ARMP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -52.61%
Profit Margin % -1,524.28%
Debt/Equity -0.74
Price/Sales 20.19
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.89
Interest Coverage -25.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar